Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Mahon

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMC Health Services Research|August 26, 2024
Regional differences in pediatric pneumococcal vaccine schedules for Indigenous children in Canada: an environmental scanSarah Mahon, Laura Reifferscheid, Lisa Kenzie, et al.
Oncology Reports|May 4, 2012
Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancerRonan W Glynn, Nicola Miller, Sarah Mahon, et al.
Rare Tumors|July 20, 2011
Primary splenic lymphoma presenting with ascitesNuala A Healy, John B Conneely, Sarah Mahon, et al.
The Oncologist|June 28, 2011
TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancerRonan W Glynn, Sarah Mahon, Catherine Curran, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazineJun Guan, Maisie Lo, Peter Dockery, et al.
The Journal of Pathology|January 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast CancerChowdhury Arif Jahangir, David B Page, Glenn Broeckx, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMC Health Services Research|August 26, 2024
Regional differences in pediatric pneumococcal vaccine schedules for Indigenous children in Canada: an environmental scanSarah Mahon, Laura Reifferscheid, Lisa Kenzie, et al.
Oncology Reports|May 4, 2012
Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancerRonan W Glynn, Nicola Miller, Sarah Mahon, et al.
Rare Tumors|July 20, 2011
Primary splenic lymphoma presenting with ascitesNuala A Healy, John B Conneely, Sarah Mahon, et al.
The Oncologist|June 28, 2011
TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancerRonan W Glynn, Sarah Mahon, Catherine Curran, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazineJun Guan, Maisie Lo, Peter Dockery, et al.
The Journal of Pathology|January 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast CancerChowdhury Arif Jahangir, David B Page, Glenn Broeckx, et al.
Pageof 1